Sensitivity of the PCR for decreasing concentrations of genomic DNA purified from <i>Veillonella</i> species using species-specific primer sets. by Izumi Mashima (3165120)

<i>PB-Cre4; SypELDTA</i> line 147 mice show decreased number of NE cells and prostate hypotrophy. by Chieh-Yang Cheng (405156)

Map of Ghana showing regional [10] and district (216) boundaries. by Alexandra V. Kulinkina (5335058)

Silencing of ATG5 gene. by Luca Galluzzi (144241)

“…(A) Time-dependent decrease in ATG5 protein in siATG5-transfected cells. …”

Table_1_Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α.XLSX by Meng Wang (124646)

Table_2_Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α.XLSX by Meng Wang (124646)

Table_3_Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α.XLSX by Meng Wang (124646)

Image_1_Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α.TIF by Meng Wang (124646)

Image_2_Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α.TIF by Meng Wang (124646)

Task: Effort and delay discounting task. by Miriam C. Klein-Flügge (713481)

DataSheet1_Mitochondrial antioxidant SkQ1 decreases inflammation following hemorrhagic shock by protecting myocardial mitochondria.docx by Bo Jia (171810)

“…The mitochondrial antioxidant SkQ1 can improve rat myocardial mitochondria ultrastructure, reduce mtDNA and ROS contents, and decrease inflammation by protecting myocardial mitochondria, thereby playing a novel protective role in HS.…”

DataSheet2_Mitochondrial antioxidant SkQ1 decreases inflammation following hemorrhagic shock by protecting myocardial mitochondria.DOCX by Bo Jia (171810)

“…The mitochondrial antioxidant SkQ1 can improve rat myocardial mitochondria ultrastructure, reduce mtDNA and ROS contents, and decrease inflammation by protecting myocardial mitochondria, thereby playing a novel protective role in HS.…”

Level of expression of activation and proliferation markers from PPD specific IFN-γ⁺CD4⁺T cells and TNF-α⁺ CD4⁺ T cells in clinically re... by Ahmed Esmael (13531723)

Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding. by Erik van Kampen (649704)

“…After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be measured. No difference was observed after 6 weeks of dietary challenge. …”

The SOD activity (a), POD activity (b), CAT activity (c), APX activity (d), GPX activity (e), and GR activity (f) in <i>R</i>. <i>pseudoacacia</i> leaves were affected by Pb stress... by Yurong Yang (300925)

Fenofibrate decreases inflammatory cell infiltration, oxidative stress and apoptosis of the sciatic nerve in <i>db/db</i> mice with VEGF inhibition. by Ye Rim Cho (505219)

“…A marked decrease in the number of unmyelinated nerve bundles (red arrowheads) and prominent axonal degeneration (red arrows) were observed in the <i>db/db</i> controls and <i>db/db</i> VEGFR12 mice. …”

Multivariate visualizations of the distance-based redundancy analysis (dbRDA) showing differences between the community structure of cryptic organisms of the ARMS sampled in the no... by Rodrigo Villalobos (4566694)

CJB111 EsxA is a pore-forming protein. by Brady L. Spencer (7294382)

Sensitivity of the optimal pathway to increased and decreased discounting (5% and 0%), to the addition of other non-cardiovascular health care costs in added years of life, the measurement of health gain in QALYs rather than DALYs, and to a reduction in the cost of statin drugs to the much lower price in New Zealand (NB. the order of interventions is altered only by the reduction in statin price, with statins becoming a more cost-effective intervention option than the blood pressure-lowering drugs). by Linda J. Cobiac (149055)

“…<p>Sensitivity of the optimal pathway to increased and decreased discounting (5% and 0%), to the addition of other non-cardiovascular health care costs in added years of life, the measurement of health gain in QALYs rather than DALYs, and to a reduction in the cost of statin drugs to the much lower price in New Zealand (NB. the order of interventions is altered only by the reduction in statin price, with statins becoming a more cost-effective intervention option than the blood pressure-lowering drugs).…”

Total CD34+KDR+ cells across pregnancy and postpartum in control, type 1 and type 2 diabetic women. by Patricia D. A. Lima (707898)